Pull to refresh
Logo
Daily Brief
Following
Why Sign Up
Steve Wise

Steve Wise

Global Head of Healthcare, Carlyle

Appears in 1 story

Stories

Medline’s $6.26B Nasdaq debut turns a PE-era debt story into a public market test

Money Moves

Senior sponsor voice for one of Medline’s controlling PE owners

Medline’s Nasdaq arrival as MDLN quickly turned from “biggest IPO of 2025” into a live market verdict: shares jumped roughly 41% in their first session, pushing the company into a roughly $50B+ valuation conversation almost immediately.

Updated Dec 20, 2025